Hester Biosciences reported a 459% YoY jump in Q1 FY27 net profit to ₹96.73 crore, while EBITDA surged to ₹111.81 crore, aided by an exceptional gain of ₹85.35 crore from the amendment of the Gates Foundation loan at Hester Africa. The company continues to focus on expanding its biologicals portfolio, exports and manufacturing efficiency.